Authors

Mark D. Tyson, MD, MPH
Recent : Urologic implications of Lynch syndrome
Northwestern Medicine
Recent : Genome-wide intricacies of cancer inhibitor untangled
Matthew Fowler
Recent : Encouraging antitumor activity seen with neoadjuvant enfortumab vedotin in patients with cisplatin-ineligible MIBC
Courtney Marabella
Recent : Update offers clues to optimal olaparib use in prostate cancer
Logan Lutton
Recent : Coaching program aims to alleviate female physician burnout
American Urogynecologic Society
Recent : Latest Resources from the American Urogynecologic Society
Darlene Dobkowski, MA
Recent : Neoadjuvant cabozantinib clinically active in renal cell carcinoma
Renee Dowling
Recent : Everything you need to know about medical coding and billing audits
Jim Lu, MD, PhD
Recent : Molecular diagnostic practice in prostate and bladder cancers

Lu is a board-certified anatomic pathologist and medical director of GoPath Laboratories LLC and GoPath Pathology Associates S.C., Buffalo Grove, Illinois.

Daniel A. Barocas, MD, MPH, FACS
Recent : Strategies to mitigate impact of intravenous ICM shortage